Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study.
Saved in:
| Title: | Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study. |
|---|---|
| Authors: | Yamaguchi Y; Pfizer Inc, Collegeville, Pennsylvania., Peeva E; Pfizer Inc, Cambridge, Massachusetts., Adiri R; Pfizer Pharmaceutical Israel LTD, Herzliya Pituach, Israel., Ghosh P; Pfizer Inc, Cambridge, Massachusetts., Napatalung L; Pfizer Inc, New York, New York; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York., Hamzavi I; Department of Dermatology, Henry Ford Hospital, Detroit, Michigan., Pandya AG; Palo Alto Foundation Medical Group, Sunnyvale, California; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas., Shore RN; Ronald N. Shore Dermatology, Rockville, Maryland., Ezzedine K; Department of Dermatology, Hôpital Henri Mondor, Creteil, France., Guttman-Yassky E; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: emma.guttman@mountsinai.org. |
| Source: | Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2025 Apr; Vol. 92 (4), pp. 781-789. Date of Electronic Publication: 2024 Dec 19. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39709084 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yamaguchi+Y%22">Yamaguchi Y</searchLink>; Pfizer Inc, Collegeville, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Peeva+E%22">Peeva E</searchLink>; Pfizer Inc, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Adiri+R%22">Adiri R</searchLink>; Pfizer Pharmaceutical Israel LTD, Herzliya Pituach, Israel.<br /><searchLink fieldCode="AU" term="%22Ghosh+P%22">Ghosh P</searchLink>; Pfizer Inc, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Napatalung+L%22">Napatalung L</searchLink>; Pfizer Inc, New York, New York; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.<br /><searchLink fieldCode="AU" term="%22Hamzavi+I%22">Hamzavi I</searchLink>; Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.<br /><searchLink fieldCode="AU" term="%22Pandya+AG%22">Pandya AG</searchLink>; Palo Alto Foundation Medical Group, Sunnyvale, California; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.<br /><searchLink fieldCode="AU" term="%22Shore+RN%22">Shore RN</searchLink>; Ronald N. Shore Dermatology, Rockville, Maryland.<br /><searchLink fieldCode="AU" term="%22Ezzedine+K%22">Ezzedine K</searchLink>; Department of Dermatology, Hôpital Henri Mondor, Creteil, France.<br /><searchLink fieldCode="AU" term="%22Guttman-Yassky+E%22">Guttman-Yassky E</searchLink>; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: emma.guttman@mountsinai.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227907132%22">Journal of the American Academy of Dermatology</searchLink> [J Am Acad Dermatol] 2025 Apr; Vol. 92 (4), pp. 781-789. <i>Date of Electronic Publication: </i>2024 Dec 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7907132 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201909622%22">01909622 </searchLink><i>NLM ISO Abbreviation: </i>J Am Acad Dermatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39709084 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jaad.2024.11.064 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 781 Titles: – TitleFull: Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yamaguchi Y – PersonEntity: Name: NameFull: Peeva E – PersonEntity: Name: NameFull: Adiri R – PersonEntity: Name: NameFull: Ghosh P – PersonEntity: Name: NameFull: Napatalung L – PersonEntity: Name: NameFull: Hamzavi I – PersonEntity: Name: NameFull: Pandya AG – PersonEntity: Name: NameFull: Shore RN – PersonEntity: Name: NameFull: Ezzedine K – PersonEntity: Name: NameFull: Guttman-Yassky E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2025 Apr Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1097-6787 Numbering: – Type: volume Value: 92 – Type: issue Value: 4 Titles: – TitleFull: Journal of the American Academy of Dermatology Type: main |
| ResultId | 1 |
